Projects per year
- 1 - 50 out of 81 results
Search results
-
Clinical Trial
Stem Cell: Biomarkers Including Putative Stem Cells Markers in Human Breast Cancers
Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Templeton, S.
3/20/14 → …
Project: Clinical Trial
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
BO41843: Phase III_GDC-9545 RO7197597_Breast Cancer_Roche BO41843: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Patients With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Niravath, P. A., Chang, J. C., Mai, H. P. & Sun, K.
Project: Clinical Trial
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C., Bernicker, E. H., Darcourt, J., Heyne, K., Niravath, P. A. & Singh, M.
4/9/20 → …
Project: Clinical Trial
-
PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2
Niravath, P. A., Chang, J. C., Heyne, K. & Singh, M.
Project: Clinical Trial
-
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Chang, J. C., Darcourt, J., Geyer, C. E. & Niravath, P. A.
Project: Clinical Trial
-
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative
Niravath, P. A., Butler, E. B., Chang, J. C., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B. & Teh, B. S.
Project: Clinical Trial
-
Converting HR Breast Cancer Into an Individualized Vaccine
Chang, J. C., Mai, H. P., Niravath, P. A. & Sun, K.
Project: Clinical Trial
-
Katherine, B50, for Treatment of Adjuvant HER2 Positive Breast Cancer
Chang, J. C., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z., Bernicker, E. H., Chang, J. C., Darcourt, J., Pingali, S. R., Sahay, S., Shah, S., Singh, M., Zhang, J., Zhou, S. & Zu, Y.
Project: Clinical Trial
-
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast
Mai, H. P., Chang, J. C., Niravath, P. A. & Sun, K.
Project: Clinical Trial
-
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Templeton, S.
Project: Clinical Trial
-
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Templeton, S., Arentz, C., Chang, J. C., Darcourt, J., Dubrovsky, E., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
Acupuncture Trial
Niravath, P. A., Chang, J. C., Heyne, K., Mai, H. P., Singh, M. & Sun, K.
Project: Clinical Trial
-
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Sun, K., Chang, J. C., Mai, H. P., Niravath, P. A. & Templeton, S.
Project: Clinical Trial
-
Emotions, Immunology and Breast Cancer: A Pilot Study
Project: Clinical Trial
-
Brain Metastases Registry
Rostomily, R. C., Baskin, D. S., Bernicker, E. H., Britz, G. W., Butler, E. B., Chang, J. C., Farach, A. M., Fung, S. H. & Teh, B. S.
Project: Clinical Trial
-
Metastatic Stem Cells-ROLE OF CANCER STEM CELLS IN BREAST CANCER RECURRENCE AND METASTASIS
Chang, J. C., Niravath, P. A. & Singh, M.
3/20/14 → …
Project: Clinical Trial
-
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo
Niravath, P. A., Abdelrahim, M., Arentz, C., Chang, J. C., Heyne, K. & Singh, M.
Project: Clinical Trial
-
Federal Funding Agencies
NY-ESO-1-specific TCR-engineered T cell immunotherapy for triple negative breast cancer
9/30/16 → 10/28/19
Project: Federal Funding Agencies
-
Functional analysis and therapeutic potential of miR-708 in triple-negative metastatic breast cancer
9/30/13 → 9/29/16
Project: Federal Funding Agencies
-
NY-ESO-1-specific TCR-Engineered T cell Immunotherapy for Triple Negative Breast Cancer
9/30/16 → 9/29/23
Project: Federal Funding Agencies
-
The inhibitory network between EZH2 and PARP1 in triple-negative breast cancer
Cao, Q., Chang, J. C. & Hu, T.
3/15/17 → 6/30/18
Project: Federal Funding Agencies
-
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Aromatase in Obese Subjects (CTMS# 15-2100)
Niravath, P. A., Chang, J. C. & Darcourt, J.
12/1/16 → 11/30/18
Project: Federal Funding Agencies
-
Convergent AI for Precise Breast Cancer Risk Assessment
Wong, S. T., Chang, J. C. & Ensor, Jr., J. E.
6/1/20 → 5/31/25
Project: Federal Funding Agencies
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Kamat, A. A., Pingali, S. R. & Singh, M.
9/20/16 → 9/20/41
Project: Federal Funding Agencies
-
Biomimetic nanovesicles to overcome multiple physiological barriers for primary and metastatic triple negative breast cancer therapy
Chang, J. C. & Rosato, R. R.
9/12/17 → 8/31/20
Project: Federal Funding Agencies
-
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis
Wong, S. T., Chang, J. C. & Sheng, J.
9/15/20 → 8/31/25
Project: Federal Funding Agencies
-
-
Targeting the Inflammasome As a Treatment Strategy for COVID-19 infected cancer patients
Chang, J. C. & Rosato, R. R.
8/17/20 → 7/31/22
Project: Federal Funding Agencies
-
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
Niravath, P. A., Chang, J. C. & Darcourt, J.
9/26/16 → 6/30/18
Project: Federal Funding Agencies
-
Tageting Notchm P13K-AKT and other novel pathways in breast cancer stem cells
8/1/11 → 7/31/13
Project: Federal Funding Agencies
-
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
6/10/22 → 5/31/27
Project: Federal Funding Agencies
-
Rationally designed orally delivered small molecules that disable erbB receptors in Breast cancer
10/1/22 → 9/30/23
Project: Federal Funding Agencies